Paolo Tarantino: Dato-DXd is the Latest ADC to Be Approved for Treating HR+/HER2- MBC

OncoDaily Oncology cancer fight against cancer Global fight against cancer cancer care ASCO Breast Cancer Lung cancer Cancer research MD Anderson Cancer Center cancer awareness ESMO Research ASCO24 NSCLC cancer treatment immunotherapy Headlines AACR prostate cancer colorectal cancer Childhood Cancer clinical trials FDA Dana-Farber Cancer Institute American Cancer Society NCI UICC European Cancer Organisation National Cancer Institute healthcare ASCO25 chemotherapy SIOP Vivek Subbiah American Society of Clinical Oncology AI WHO Paolo Tarantino Zainab Shinkafi-Bagudu Memorial Sloan Kettering Cancer Center multiple myeloma cervical cancer patient care American Association for Cancer Research Robert Orlowski radiation oncology Sylvester Comprehensive Cancer Center IASLC Sitemap All Tags »